Primary Myelofibrosis clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    To assess the safety and tolerability of CK0804 as add-on therapy in participants with myelofibrosis, with suboptimal response to ruxolitinib

    Sacramento, California and other locations

Our lead scientists for Primary Myelofibrosis research studies include .